{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["SARS-CoV-2", "alkaloids", "coronavirus", "medicinal plant", "natural product"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35355337", "DateCompleted": {"Year": "2022", "Month": "07", "Day": "22"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "03", "Day": "30"}], "Language": ["eng"], "ELocationID": ["10.1002/ptr.7442"], "Journal": {"ISSN": "1099-1573", "JournalIssue": {"Volume": "36", "Issue": "7", "PubDate": {"Year": "2022", "Month": "Jul"}}, "Title": "Phytotherapy research : PTR", "ISOAbbreviation": "Phytother Res"}, "ArticleTitle": "The naturally-derived alkaloids as a potential treatment for COVID-19: A scoping review.", "Pagination": {"StartPage": "2686", "EndPage": "2709", "MedlinePgn": "2686-2709"}, "Abstract": {"AbstractText": ["Coronavirus disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which has a high mortality rate and transmissibility. In this context, medicinal plants have attracted attention due to the wide availability and variety of therapeutic compounds, such as alkaloids, a vast class with several proven pharmacological effects, like the antiviral and anti-inflammatory activities. Therefore, this scoping review aimed to summarize the current knowledge of the potential applicability of alkaloids for treating COVID-19. A systematic search was performed on PubMed and Scopus, from database inception to August 2021. Among the 63 eligible studies, 65.07% were in silico model, 20.63% in vitro and 14.28% clinical trials and observational studies. According to the in silico assessments, the alkaloids 10-hydroxyusambarensine, cryptospirolepine, crambescidin 826, deoxynortryptoquivaline, ergotamine, michellamine B, nigellidine, norboldine and quinadoline B showed higher binding energy with more than two target proteins. The remaining studies showed potential use of berberine, cephaeline, emetine, homoharringtonine, lycorine, narciclasine, quinine, papaverine and colchicine. The possible ability of alkaloids to inhibit protein targets and to reduce inflammatory markers show the potential for development of new treatment strategies against COVID-19. However, more high quality analyses/reviews in this field are necessary to firmly establish the effectiveness/safety of the alkaloids here described."], "CopyrightInformation": "\u00a9 2022 John Wiley & Sons Ltd."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centro Universit\u00e1rio Ing\u00e1-UNING\u00c1, Maring\u00e1, Paran\u00e1, Brazil."}], "LastName": "Gonzalez", "ForeName": "B\u00e1rbara Longhini", "Initials": "BL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departamento de Farm\u00e1cia, Universidade Estadual de Maring\u00e1-UEM, Maring\u00e1, Paran\u00e1, Brazil."}], "LastName": "de Oliveira", "ForeName": "Natalia Castelhano", "Initials": "NC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departamento de Farm\u00e1cia, Universidade Estadual de Maring\u00e1-UEM, Maring\u00e1, Paran\u00e1, Brazil."}], "LastName": "Ritter", "ForeName": "Mariane Roberta", "Initials": "MR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Programa de P\u00f3s-gradua\u00e7\u00e3o em Ci\u00eancias Farmac\u00eauticas, Universidade Federal do Paran\u00e1-UFPR, Curitiba, Paran\u00e1, Brazil."}], "LastName": "Tonin", "ForeName": "Fernanda Stumpf", "Initials": "FS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centro de Ci\u00eancias M\u00e9dicas e Farmac\u00eauticas, Universidade Estadual do Oeste do Paran\u00e1-UNIOESTE, Cascavel, Paran\u00e1, Brazil."}], "LastName": "Melo", "ForeName": "Eduardo Borges", "Initials": "EB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centro de Ci\u00eancias M\u00e9dicas e Farmac\u00eauticas, Universidade Estadual do Oeste do Paran\u00e1-UNIOESTE, Cascavel, Paran\u00e1, Brazil."}], "LastName": "Sanches", "ForeName": "Andr\u00e9ia Cristina Conegero", "Initials": "ACC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departamento de Ci\u00eancias do Medicamento, Universidade do Porto, Porto, Portugal."}], "LastName": "Fernandez-Llimos", "ForeName": "Fernando", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Hospital Santa Rita, Maring\u00e1, Paran\u00e1, Brazil."}], "LastName": "Petruco", "ForeName": "Marcus Vin\u00edcius", "Initials": "MV"}, {"Identifier": ["0000-0002-7532-3395"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departamento de Farm\u00e1cia, Universidade Estadual de Maring\u00e1-UEM, Maring\u00e1, Paran\u00e1, Brazil."}], "LastName": "de Mello", "ForeName": "Jo\u00e3o Carlos Palazzo", "Initials": "JCP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departamento de Farm\u00e1cia, Universidade Estadual de Maring\u00e1-UEM, Maring\u00e1, Paran\u00e1, Brazil."}], "LastName": "Chierrito", "ForeName": "Danielly", "Initials": "D"}, {"Identifier": ["0000-0001-8602-035X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centro Universit\u00e1rio Ing\u00e1-UNING\u00c1, Maring\u00e1, Paran\u00e1, Brazil."}], "LastName": "de Medeiros Ara\u00fajo", "ForeName": "Daniela Cristina", "Initials": "DC"}], "PublicationTypeList": ["Journal Article", "Review", "Systematic Review"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Phytother Res", "NlmUniqueID": "8904486", "ISSNLinking": "0951-418X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "pharmacology", "therapeutic use"], "DescriptorName": "Alkaloids"}, {"QualifierName": ["chemistry", "pharmacology", "therapeutic use"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}], "CoiStatement": "The authors declare that there is no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Abd El\u2010Aziz, N. M. , Eldin Awad, O. M. , Shehata, M. G. , & El\u2010Sohaimy, S. A. (2021). Inhibition of the SARS\u2010CoV\u20102 RNA\u2010dependent RNA polymerase by natural bioactive compounds: Molecular docking analysis. Egyptian Journal of Chemistry, 64(4), 1989\u20132001."}, {"Citation": "Aftab, S. O. , Ghouri, M. Z. , Masood, M. U. , Haider, Z. , Khan, Z. , Ahmad, A. , & Munawar, N. (2020). Analysis of SARS\u2010CoV\u20102 RNA\u2010dependent RNA polymerase as a potential therapeutic drug target using a computational approach. Journal of Translational Medicine, 18(1), 275.", "ArticleIdList": ["PMC7339606", "32635935"]}, {"Citation": "Alfaro, M. , Alfaro, I. , & Angel, C. (2020). Identification of potential inhibitors of SARS\u2010CoV\u20102 papain\u2010like protease from tropane alkaloids from Schizanthus porrigens: A molecular docking study. Chemical Physics Letters, 761. 10.1016/j.cplett.2020.138068", "ArticleIdList": ["10.1016/j.cplett.2020.138068", "PMC7540197", "33052144"]}, {"Citation": "Asselah, T. , Durantel, D. , Pasmant, E. , Lau, G. , & Schinazi, R. F. (2020). COVID\u201019: Discovery, diagnostics and drug development. Journal of Hepatology, 74(1), 168\u2013184. 10.1016/j.jhep.2020.09.031", "ArticleIdList": ["10.1016/j.jhep.2020.09.031", "PMC7543767", "33038433"]}, {"Citation": "Asuzu, C. U. , & Nwosu, M. O. (2020). Studies of the wood of some Nigerian alkaloid\u2010rich Strychnos species. Journal of Horticulture and Forestry, 12(2), 57\u201362."}, {"Citation": "Axfors, C. , Schmitt, A. M. , Janiaud, P. , van't Hooft, J. , Abd\u2010Elsalam, S. , Abdo, E. F. , \u2026 Hemkens, L. G. (2021). Mortality outcomes with hydroxychloroquine and chloroquine in COVID\u201019 from an international collaborative meta\u2010analysis of randomized trials. Nature Communications, 12(1), 1\u201313.", "ArticleIdList": ["PMC8050319", "33859192"]}, {"Citation": "Batool, A. , Bibi, N. , Amin, F. , & Amjad, M. (2020). Drug designing against NSP15 of SARS\u2010COV2 via high throughput computational screening and structural dynamics approach. European Journal of Pharmacology, 892, 1\u20138. 10.1016/j.ejphar.2020.173779", "ArticleIdList": ["10.1016/j.ejphar.2020.173779", "PMC7706467", "33275961"]}, {"Citation": "Boozari, M. , & Hosseinzadeh, H. (2021). Natural products for COVID\u201019 prevention and treatment regarding to previous coronavirus infections and novel studies. Phytotherapy Research, 35(2), 864\u2013876.", "ArticleIdList": ["32985017"]}, {"Citation": "Borquaye, L. S. , Gasu, E. N. , Ampomah, G. B. , Kyei, L. K. , Amarh, M. A. , Mensah, C. N. , \u2026 Aboagye, C. I. (2020). Alkaloids from Cryptolepis sanguinolenta as potential inhibitors of SARS\u2010CoV\u20102 viral proteins: An in silico study. BioMed Research International. 10.1155/2020/5324560", "ArticleIdList": ["10.1155/2020/5324560", "PMC7512045", "33029513"]}, {"Citation": "Bouvet, M. , Lugari, A. , Posthuma, C. C. , Zevenhoven, J. C. , Bernard, S. , Betzi, S. , \u2026 Morelli, X. (2014). Coronavirus Nsp10, a critical co\u2010factor for activation of multiple replicative enzymes. Journal of Biological Chemistry, 289(37), 25783\u201325796.", "ArticleIdList": ["PMC4162180", "25074927"]}, {"Citation": "Bribi, N. (2018). Pharmacological activity of aporphinoid alkaloids: A review. Asian Journal of Botany, 1(5), 387\u2013412."}, {"Citation": "Brunetti, L. , Diawara, O. , Tsai, A. , Firestein, B. L. , Nahass, R. G. , Poiani, G. , & Schlesinger, N. (2020). Colchicine to weather the cytokine storm in hospitalized patients with COVID\u201019. Journal of Clinical Medicine, 9(9), 2961.", "ArticleIdList": ["PMC7565543", "32937800"]}, {"Citation": "Buonaguro, L. , Tagliamonte, M. , Tornesello, M. L. , & Buonaguro, F. M. (2020, May). SARS\u2010CoV\u20102 RNA polymerase as target for antiviral therapy. Journal of Translational Medicine. 10.1186/s12967-020-02355-3", "ArticleIdList": ["10.1186/s12967-020-02355-3", "PMC7200052", "32370758"]}, {"Citation": "Ceriotti, G. (1967). Narciclasine: An antimitotic substance from narcissus bulbs. Nature, 213(5076), 595\u2013596.", "ArticleIdList": ["5340258"]}, {"Citation": "Chen, Y. , Lear, T. B. , Evankovich, J. W. , Larsen, M. B. , Lin, B. , Alfaras, I. , \u2026 Chen, B. B. (2021). A high\u2010throughput screen for TMPRSS2 expression identifies FDA\u2010approved compounds that can limit SARS\u2010CoV\u20102 entry. Nature Communications, 12(1). 10.1038/s41467-021-24156-y", "ArticleIdList": ["10.1038/s41467-021-24156-y", "PMC8222394", "34162861"]}, {"Citation": "Choy, K. T. , Wong, A. Y. L. , Kaewpreedee, P. , Sia, S. F. , Chen, D. , Hui, K. P. Y. , \u2026 Yen, H. L. (2020). Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS\u2010CoV\u20102 replication in vitro. Antiviral Research, 178, 104786.", "ArticleIdList": ["PMC7127386", "32251767"]}, {"Citation": "Dai, W. , Zhang, B. , Jiang, X. M. , Su, H. , Li, J. , Zhao, Y. , \u2026 Liu, H. (2020). Structure\u2010based design of antiviral drug candidates targeting the SARS\u2010CoV\u20102 main protease. Science, 368(6497), 1331\u20131335.", "ArticleIdList": ["PMC7179937", "32321856"]}, {"Citation": "Danwang, C. , Endomba, F. T. , Nkeck, J. R. , Wouna, D. L. A. , Robert, A. , & Noubiap, J. J. (2020). A meta\u2010analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID\u201019). Biomarker Research, 8(1). 10.1186/s40364-020-00217-0", "ArticleIdList": ["10.1186/s40364-020-00217-0", "PMC7456766", "32879731"]}, {"Citation": "Das, S. , Sarmah, S. , Lyndem, S. , & Singha Roy, A. (2020). An investigation into the identification of potential inhibitors of SARS\u2010CoV\u20102 main protease using molecular docking study. Journal of Biomolecular Structure and Dynamics, 39(9), 3347\u20133357.", "ArticleIdList": ["PMC7232884", "32362245"]}, {"Citation": "de Leon, V. N. O. , Manzano, J. A. H. , Pilapil, D. Y. H. , Fernandez, R. A. T. , Ching, J. K. A. R. , Quimque, M. T. J. , \u2026 Macabeo, A. P. G. (2021). Anti\u2010HIV reverse transcriptase plant polyphenolic natural products with in silico inhibitory properties on seven non\u2010structural proteins vital in SARS\u2010CoV\u20102 pathogenesis. Journal of Genetic Engineering and Biotechnology, 19(1). 10.1186/s43141-021-00206-2", "ArticleIdList": ["10.1186/s43141-021-00206-2", "PMC8284420", "34272647"]}, {"Citation": "de S\u00e1, \u00c9. R. A. , Costa, A. N. , Costa, R. K. M. , Souza, J. L. , Ramos, R. M. , Lima, F. , & das, C. A. (2021). In silico study of the interactions of Pilocarpus microphyllus imidazolic alkaloids with the main protease (Mpro) of SARS\u2010CoV\u20102. Molecular Simulation, 47(1), 74\u201387. 10.1080/08927022.2021.1873321", "ArticleIdList": ["10.1080/08927022.2021.1873321"]}, {"Citation": "Deftereos, S. G. , Giannopoulos, G. , Vrachatis, D. A. , Siasos, G. D. , Giotaki, S. G. , Gargalianos, P. , \u2026 Stefanadis, C. (2020). Effect of colchicine versus standard care on cardiac and inflammatory biomarkers and clinical outcomes in patients hospitalized with coronavirus disease 2019: The GRECCO\u201019 randomized clinical trial. JAMA Network Open, 3(6), 1\u201314.", "ArticleIdList": ["PMC7315286", "32579195"]}, {"Citation": "Deng, X. , Hackbart, M. , Mettelman, R. C. , O'Brien, A. , Mielech, A. M. , Yi, G. , \u2026 Baker, S. C. (2017). Coronavirus nonstructural protein 15 mediates evasion of dsRNA sensors and limits apoptosis in macrophages. Proceedings of the National Academy of Sciences of the United States of America, 114(21), E4251\u2013E4260.", "ArticleIdList": ["PMC5448190", "28484023"]}, {"Citation": "Devasia, R. M. , Mohammad, A. , Alrefaei, A. F. , & Manoharadas, S. (2021). Enhanced production of camptothecin by immobilized callus of Ophiorrhiza mungos and a bioinformatic insight into its potential antiviral effect against SARS\u2010CoV\u20102. Journal of King Saud University\u2014Science, 33, 1\u20138. 10.1016/j.jksus.2021.101344", "ArticleIdList": ["10.1016/j.jksus.2021.101344", "PMC7826111", "33531790"]}, {"Citation": "Diaz\u2010Arocutipa, C. , Benites\u2010Meza, J. K. , Chambergo\u2010Michilot, D. , Barboza, J. J. , Pasupuleti, V. , Bueno, H. , \u2026 Hernandez, A. V. (2021). Efficacy and safety of colchicine in post\u2013acute myocardial infarction patients: A systematic review and meta\u2010analysis of randomized controlled trials. Frontiers in Cardiovascular Medicine, 8. 10.3389/fcvm.2021.676771", "ArticleIdList": ["10.3389/fcvm.2021.676771", "PMC8217746", "34169101"]}, {"Citation": "El\u2010Demerdash, A. , Metwaly, A. M. , Hassan, A. , El\u2010Aziz, T. M. A. , Elkaeed, E. B. , Eissa, I. H. , \u2026 Stockand, J. D. (2021). Comprehensive virtual screening of the antiviral potentialities of marine polycyclic guanidine alkaloids against SARS\u2010CoV\u20102 (COVID\u201019). Biomolecules, 11(3), 1\u201325.", "ArticleIdList": ["PMC8003478", "33808721"]}, {"Citation": "Ellinger, B. , Bojkova, D. , Zaliani, A. , Cinatl, J. , Claussen, C. , Westhaus, S. , \u2026 Ciesek, S. (2021). A SARS\u2010CoV\u20102 cytopathicity dataset generated by high\u2010content screening of a large drug repurposing collection. Scientific Data, 8(1), 2\u201311.", "ArticleIdList": ["PMC7910569", "33637768"]}, {"Citation": "Elshazli, R. M. , Toraih, E. A. , Elgaml, A. , El\u2010Mowafy, M. , El\u2010Mesery, M. , Amin, M. N. , \u2026 Kandil, E. (2020). Diagnostic and prognostic value of hematological and immunological markers in COVID\u201019 infection: A meta\u2010analysis of 6320 patients. PLoS One, 15(8), 1\u201320.", "ArticleIdList": ["PMC7446892", "32822430"]}, {"Citation": "Elzupir, A. O. (2020). Caffeine and caffeine\u2010containing pharmaceuticals as promising inhibitors for 3\u2010chymotrypsin\u2010like protease of SARS\u2010CoV\u20102. Journal of Biomolecular Structure and Dynamics, 40(5), 2113\u20132120. 10.1080/07391102.2020.1835732", "ArticleIdList": ["10.1080/07391102.2020.1835732", "PMC7594182", "33094705"]}, {"Citation": "Fan, S. , Zhen, Q. , Chen, C. , Wang, W. , Wu, Q. , Ma, H. , \u2026 Zhang, L. (2021). Clinical efficacy of low\u2010dose emetine for patients with COVID\u201019: A real\u2010world study. Journal of Bio\u2010X Research, 4, 53\u201359.", "ArticleIdList": ["PMC8237841", "34254034"]}, {"Citation": "Fielding, B. C. , Filho, C. S. M. B. , Ismail, N. S. M. , & de Sousa, D. P. (2020). Alkaloids: Therapeutic potential against human coronaviruses. Molecules, 25(23). 10.3390/molecules25235496", "ArticleIdList": ["10.3390/molecules25235496", "PMC7727683", "33255253"]}, {"Citation": "Firdiana, E. R. , Renjana, E. , Ningrum, L. W. , Angio, M. H. , Nikmatullah, M. , & Rizal, S. (2021). In Silico study of the active compounds of Lindera aggregata (Sims) Kosterm as anti\u2010coronavirus. Current Nutrition & Food Science, 17(4), 408\u2013416."}, {"Citation": "Singh, S. , & Florez, H. (2020). Bioinformatic study to discover natural molecules with activity against COVID\u201019 [version 1; peer review: 2 approved]. F1000Research, 9, 1\u201315. 10.12688/f1000research.26731.1", "ArticleIdList": ["10.12688/f1000research.26731.1", "PMC7590895", "33145015"]}, {"Citation": "Garg, S. , & Roy, A. (2020). In silico analysis of selected alkaloids against main protease (Mpro) of SARS\u2010CoV\u20102. Chemico\u2010Biological Interactions, 332, 109309.", "ArticleIdList": ["PMC7649659", "33181114"]}, {"Citation": "Gendrot, M. , Andreani, J. , Boxberger, M. , Jardot, P. , Fonta, I. , Le Bideau, M. , \u2026 Pradines, B. (2020). Antimalarial drugs inhibit the replication of SARS\u2010CoV\u20102: An in vitro evaluation. Travel Medicine and Infectious Disease, 37, 1\u20136.", "ArticleIdList": ["PMC7477610", "32916297"]}, {"Citation": "Ghosh, R. , Chakraborty, A. , Biswas, A. , & Chowdhuri, S. (2020). Identification of alkaloids from Justicia adhatoda as potent SARS CoV\u20102 main protease inhibitors: An in silico perspective. Journal of Molecular Structure, 1229, 129489.", "ArticleIdList": ["PMC7571971", "33100380"]}, {"Citation": "Gro\u00dfe, M. , Ruetalo, N. , Layer, M. , Hu, D. , Businger, R. , Rheber, S. , \u2026 Schubert, U. (2021). Quinine inhibits infection of human cell lines with SARS\u2010CoV\u20102. Viruses, 13(4), 1\u201317.", "ArticleIdList": ["PMC8069458", "33918670"]}, {"Citation": "Gul, S. , Ozcan, O. , Asar, S. , Okyar, A. , Bar\u0131s, I. , & Kavakli, I. H. (2020). In silico identification of widely used and well\u2010tolerated drugs as potential SARS\u2010CoV\u20102 3C\u2010like protease and viral RNA\u2010dependent RNA polymerase inhibitors for direct use in clinical trials. Journal of Biomolecular Structure and Dynamics, 39(17), 6772\u20136791. 10.1080/07391102.2020.1802346", "ArticleIdList": ["10.1080/07391102.2020.1802346", "PMC7484590", "32752938"]}, {"Citation": "Gurung, A. B. , Ali, M. A. , Lee, J. , Abul Farah, M. , & Al\u2010Anazi, K. M. (2020). Structure\u2010based virtual screening of phytochemicals and repurposing of FDA approved antiviral drugs unravels lead molecules as potential inhibitors of coronavirus 3C\u2010like protease enzyme. Journal of King Saud University\u2014Science, 32, 2845\u20132853.", "ArticleIdList": ["PMC7366079", "32837113"]}, {"Citation": "Gurung, A. B. , Ali, M. A. , Lee, J. , Farah, M. A. , & Al\u2010Anazi, K. M. (2021). The potential of Paritaprevir and emetine as inhibitors of SARS\u2010CoV\u20102 RdRp. Saudi Journal of Biological Sciences, 28(2), 1426\u20131432.", "ArticleIdList": ["PMC7708801", "33281478"]}, {"Citation": "Gyebi, G. A. , Adegunloye, A. P. , Ibrahim, I. M. , Ogunyemi, O. M. , Afolabi, S. O. , & Ogunro, O. B. (2020). Prevention of SARS\u2010CoV\u20102 cell entry: Insight from in silico interaction of drug\u2010like alkaloids with spike glycoprotein, human ACE2, and TMPRSS2. Journal of Biomolecular Structure and Dynamics, 40, 1\u201325.", "ArticleIdList": ["PMC7594191", "33089728"]}, {"Citation": "Gyebi, G. A. , Ogunro, O. B. , Adegunloye, A. P. , Ogunyemi, O. M. , & Afolabi, S. O. (2020). Potential inhibitors of coronavirus 3\u2010chymotrypsin\u2010like protease (3CLpro): An in silico screening of alkaloids and terpenoids from African medicinal plants. Journal of Biomolecular Structure and Dynamics, 39(9), 3396\u20133408.", "ArticleIdList": ["PMC7256353", "32367767"]}, {"Citation": "\n\nHiggins, J.\n, & \nThomas, J.\n (2021). \nCochrane handbook for systematic reviews of interventions. Version 6.2\n. https://training.cochrane.org/handbook/current\n", "ArticleIdList": ["PMC10284251", "31643080"]}, {"Citation": "Hoffmann, M. , M\u00f6sbauer, K. , Hofmann\u2010Winkler, H. , Kaul, A. , Kleine\u2010Weber, H. , Kr\u00fcger, N. , \u2026 P\u00f6hlmann, S. (2020). Chloroquine does not inhibit infection of human lung cells with SARS\u2010CoV\u20102. Nature, 585(7826), 588\u2013590. 10.1038/s41586-020-2575-3", "ArticleIdList": ["10.1038/s41586-020-2575-3", "32698190"]}, {"Citation": "Huang, C. T. , Chao, T. L. , Kao, H. C. , Pang, Y. H. , Lee, W. H. , Hsieh, C. H. , \u2026 Juan, H. F. (2020). Enhancement of the IFN\u2010\u03b2\u2010induced host signature informs repurposed drugs for COVID\u201019. Heliyon, 6(12), 1\u20139.", "ArticleIdList": ["PMC7709728", "33289002"]}, {"Citation": "Ianevski, A. , Yao, R. , Fenstad, M. H. , Biza, S. , Zusinaite, E. , Reisberg, T. , \u2026 Kainov, D. E. (2020). Potential antiviral options against SARS\u2010CoV\u20102 infection. Viruses, 12(6), 1\u201320.", "ArticleIdList": ["PMC7354438", "32545799"]}, {"Citation": "Imenshahidi, M. , & Hosseinzadeh, H. (2019). Berberine and barberry (Berberis vulgaris): A clinical review. Phytotherapy Research, 33(3), 504\u2013523.", "ArticleIdList": ["30637820"]}, {"Citation": "Islam, M. T. , El\u2010kersh, C. S. D. M. , Jamaddar, S. , Uddin, S. J. , Shilpi, J. A. , & Mubarak, M. S. (2020). Natural products and their derivatives against coronavirus: A review of the non\u2010clinical and pre\u2010clinical data. Phytotherapy Research, 34, 2471\u20132492.", "ArticleIdList": ["32248575"]}, {"Citation": "Ismail, E. M. O. A. , Shantier, S. W. , Mohammed, M. S. , Musa, H. H. , Osman, W. , & Mothana, R. A. (2021). Quinoline and quinazoline alkaloids against Covid\u201019: An in silico multitarget approach. Journal of Chemistry. 10.1155/2021/3613268", "ArticleIdList": ["10.1155/2021/3613268"]}, {"Citation": "Jade, D. , Ayyamperumal, S. , Tallapaneni, V. , Joghee Nanjan, C. M. , Barge, S. , Mohan, S. , & Nanjan, M. J. (2021). Virtual high throughput screening: Potential inhibitors for SARS\u2010CoV\u20102 PLPRO and 3CLPRO proteases. European Journal of Pharmacology, 901. 10.1016/j.ejphar.2021.174082", "ArticleIdList": ["10.1016/j.ejphar.2021.174082", "PMC8018918", "33823185"]}, {"Citation": "Jin, Y. H. , Min, J. S. , Jeon, S. , Lee, J. , Kim, S. , Park, T. , \u2026 Kwon, S. (2021). Lycorine, a non\u2010nucleoside RNA dependent RNA polymerase inhibitor, as potential treatment for emerging coronavirus infections. Phytomedicine, 86, 153440.", "ArticleIdList": ["PMC7738280", "33376043"]}, {"Citation": "\nJoanna Briggs Institute\n. (2015). \nMethodology for JBI scoping reviews Joanna Briggs Institute\n. Manual. https://joannabriggs.org/assets/docs/sumari/Reviewers-Manual_Methodology-for-JBI-Scoping-Reviews_2015_v2.pdf\n"}, {"Citation": "Kandeel, M. , Abdelrahman, A. H. M. , Oh\u2010Hashi, K. , Ibrahim, A. , Venugopala, K. N. , Morsy, M. A. , & Ibrahim, M. A. A. (2020). Repurposing of FDA\u2010approved antivirals, antibiotics, anthelmintics, antioxidants, and cell protectives against SARS\u2010CoV\u20102 papain\u2010like protease. Journal of Biomolecular Structure & Dynamics. 10.1080/07391102.2020.1784291", "ArticleIdList": ["10.1080/07391102.2020.1784291", "PMC7332862", "32597315"]}, {"Citation": "Kawase, M. , Shirato, K. , van der Hoek, L. , Taguchi, F. , & Matsuyama, S. (2012). Simultaneous Treatment of Human Bronchial Epithelial Cells with Serine and Cysteine Protease Inhibitors Prevents Severe Acute Respiratory Syndrome Coronavirus Entry. Journal of Virology, 86(12), 6537\u20136545. 10.1128/jvi.00094-12", "ArticleIdList": ["10.1128/jvi.00094-12", "PMC3393535", "22496216"]}, {"Citation": "Khan, R. J. , Jha, R. K. , Amera, G. M. , Jain, M. , Singh, E. , Pathak, A. , \u2026 Singh, A. K. (2021). Targeting SARS\u2010CoV\u20102: A systematic drug repurposing approach to identify promising inhibitors against 3C\u2010like proteinase and 2\u2032\u2010O\u2010ribose methyltransferase. Journal of Biomolecular Structure & Dynamics, 39(8), 2679\u20132692.", "ArticleIdList": ["PMC7189412", "32266873"]}, {"Citation": "Kumar, D. , Kumari, K. , Jayaraj, A. , Kumar, V. , Kumar, R. V. , Dass, S. K. , \u2026 Singh, P. (2020). Understanding the binding affinity of noscapines with protease of SARS\u2010CoV\u20102 for COVID\u201019 using MD simulations at different temperatures. Journal of Biomolecular Structure and Dynamics, 39(7), 2659\u20132672.", "ArticleIdList": ["PMC7212547", "32362235"]}, {"Citation": "Kumar, N. , Awasthi, A. , Kumari, A. , Sood, D. , Jain, P. , Singh, T. , \u2026 Chandra, R. (2020). Antitussive noscapine and antiviral drug conjugates as arsenal against COVID\u201019: A comprehensive chemoinformatics analysis. Journal of Biomolecular Structure and Dynamics, 40, 1\u201316.", "ArticleIdList": ["PMC7484584", "32815796"]}, {"Citation": "Kumar, C. S. , Kumar, S. A. , & Wei, H. (2020). Comparative docking studies to understand the binding affinity of nicotine with soluble ACE2 (sACE2)\u2010SARS\u2010CoV\u20102 complex over sACE2. Toxicology Reports, 7, 1366\u20131372.", "ArticleIdList": ["PMC7543737", "33052306"]}, {"Citation": "Kumar, N. , Sood, D. , van der Spek, P. J. , Sharma, H. S. , & Chandra, R. (2020). Molecular binding mechanism and pharmacology comparative analysis of noscapine for repurposing against SARS\u2010CoV\u20102 protease. Journal of Proteome Research, 19(11), 4678\u20134689.", "ArticleIdList": ["32786685"]}, {"Citation": "Kumar, R. , Afsar, M. , Khandelwal, N. , Chander, Y. , Riyesh, T. , Dedar, R. K. , \u2026 Kumar, N. (2021). Emetine supresses SARS\u2010CoV\u20102 replication by inhibiting interaction of viral mRNA with eIF4E. Antiviral Research, 189, 1\u20136.", "ArticleIdList": ["PMC7943376", "33711336"]}, {"Citation": "Kumar, Y. , Singh, H. , & Patel, C. N. (2020). In silico prediction of potential inhibitors for the main protease of SARS\u2010CoV\u20102 using molecular docking and dynamics simulation based. Journal of Infection and Public Health, 12, 1210\u20131223.", "ArticleIdList": ["PMC7297718", "32561274"]}, {"Citation": "Lestari, K. , Sitorus, T. , Instiaty, Megantara, S. , & Levita, J. (2020). Molecular docking of quinine, chloroquine and hydroxychloroquine to angiotensin converting enzyme 2 (ACE2) receptor for discovering new potential COVID\u201019 antidote. Journal of Advanced Pharmacy Education and Research, 10(2), 1\u20134."}, {"Citation": "Li, J. , Han, T. , Woodward, M. , Anderson, C. S. , Zhou, H. , Chen, Y.\u2010D. , & Neal, B. (2020). Special article\u2014The impact of 2019 novel coronavirus on heart injury: A systematic review and meta\u2010analysis. Progress in Cardiovascular Diseases, 63, 518\u2013524.", "ArticleIdList": ["PMC7160645", "32305557"]}, {"Citation": "Lin, H. X. J. , Cho, S. , Meyyur Aravamudan, V. , Sanda, H. Y. , Palraj, R. , Molton, J. S. , & Venkatachalam, I. (2021). Remdesivir in coronavirus disease 2019 (COVID\u201019) treatment: A review of evidence. Infection, 49(3), 401\u2013410.", "ArticleIdList": ["PMC7778417", "33389708"]}, {"Citation": "Lopes, M. I. , Bonjorno, L. P. , Giannini, M. C. , Amaral, N. B. , Menezes, P. I. , Dib, S. M. , \u2026 Oliveira, R. D. R. (2021). Beneficial effects of colchicine for moderate to severe COVID\u201019: A randomised, double\u2010blinded, placebo\u2010controlled clinical trial. RMD Open, 7(1), 1\u20138.", "ArticleIdList": ["PMC7868202", "33542047"]}, {"Citation": "Maiti, S. , Banerjee, A. , & Kanwar, M. (2021). In silico Nigellidine (N. sativa) bind to viral spike/active\u2010sites of ACE1/2, AT1/2 to prevent COVID\u201019 induced vaso\u2010tumult/vascular\u2010damage/comorbidity. Vacular Pharmacology, 138, 106856.", "ArticleIdList": ["PMC7970800", "33746069"]}, {"Citation": "Maiti, S. , Banerjee, A. , Nazmeen, A. , Kanwar, M. , & Das, S. (2020). Active\u2010site molecular docking of nigellidine with nucleocapsid\u2010NSP2\u2010MPro of COVID\u201019 and to human IL1R\u2010IL6R and strong antioxidant role of Nigella\u2010sativa in experimental rats. Journal of Drug Targeting, 2330, 1\u201323.", "ArticleIdList": ["32875925"]}, {"Citation": "Manenti, L. , Maggiore, U. , Fiaccadori, E. , Meschi, T. , Antoni, A. D. , Nouvenne, A. , \u2026 Peruzzi, L. (2021). Reduced mortality in COVID\u201019 patients treated with colchicine: Results from a retrospective, observational study. PLoS One, 16, 1\u201311.", "ArticleIdList": ["PMC7990208", "33760858"]}, {"Citation": "Mao, R. , Bie, L. , Xu, M. , Wang, X. , & Gao, J. (2021). Antiviral drug design based on the opening mechanism of spike glycoprotein in SARS\u2010CoV\u20102. Physical Chemistry Chemical Physics, 23(22), 12549\u201312558.", "ArticleIdList": ["34008647"]}, {"Citation": "Mareev, V. Y. , Orlova, Y. A. , Plisyk, A. G. , Pavlikova, E. P. , Akopyan, Z. A. , Matskeplishvili, S. , \u2026 Kamalov, A. A. (2021). Proactive anti\u2010inflammatory therapy with colchicine in the treatment of advanced stages of new coronavirus infection. The first results of the COLORIT study. Kardiologiya, 61(2), 15\u201327.", "ArticleIdList": ["33734043"]}, {"Citation": "Martino, E. , Della Volpe, S. , Terribile, E. , Benetti, E. , Sakaj, M. , Centamore, A. , \u2026 Collina, S. (2017). The long story of camptothecin: From traditional medicine to drugs. Bioorganic and Medicinal Chemistry Letters, 27(4), 701\u2013707. 10.1016/j.bmcl.2016.12.085", "ArticleIdList": ["10.1016/j.bmcl.2016.12.085", "28073672"]}, {"Citation": "Maurya, V. K. , Kumar, S. , Prasad, A. K. , Bhatt, M. L. B. , & Saxena, S. K. (2020). Structure\u2010based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS\u2010CoV\u20102 spike glycoprotein and its cellular receptor. VirusDisease, 31(2), 179\u2013193.", "ArticleIdList": ["PMC7245990", "32656311"]}, {"Citation": "Mohammadi, S. , Heidarizadeh, M. , Entesari, M. , Esmailpour, A. , Esmailpour, M. , Moradi, R. , \u2026 Doustkhah, E. (2020). In silico investigation on the inhibiting role of nicotine/caffeine by blocking the s protein of sars\u2010cov\u20102 versus ace2 receptor. Microorganisms, 8(10), 1\u201314.", "ArticleIdList": ["PMC7603175", "33080900"]}, {"Citation": "Mostafa, E. M. , Gamal, M. , Ghoneim, M. M. , Hussein, S. , El\u2010Ghorab, A. H. , Abdelgawad, M. A. , & Musa, A. (2021). Repurposing of FDA approved alkaloids as COVID 19 inhibitors; in silico studies. Pharmacognosy Journal, 13(1), 110\u2013123."}, {"Citation": "Newman, D. J. , & Cragg, G. M. (2020). Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. Journal of Natural Products, 83(3), 770\u2013803.", "ArticleIdList": ["32162523"]}, {"Citation": "Ogunyemi, O. M. , Gyebi, G. A. , Elfiky, A. A. , Afolabi, S. O. , Ogunro, O. B. , Adegunloye, A. P. , & Ibrahim, I. M. (2020). Alkaloids and flavonoids from African phytochemicals as potential inhibitors of SARS\u2010Cov\u20102 RNA\u2010dependent RNA polymerase: An in silico perspective. Antiviral Chemistry and Chemotherapy, 28, 1\u201315.", "ArticleIdList": ["PMC7783895", "33372806"]}, {"Citation": "Osafo, N. , Mensah, K. B. , & Yeboah, O. K. (2017). Phytochemical and pharmacological review of Cryptolepis sanguinolenta (Lindl.) Schlechter. Advances in Pharmacological Sciences. 10.1155/2017/3026370", "ArticleIdList": ["10.1155/2017/3026370", "PMC5661077", "29750083"]}, {"Citation": "Osipiuk, J. , Azizi, S.\u2010A. , Dvorkin, S. , Endres, M. , Jedrzejczak, R. , Jones, K. A. , \u2026 Joachimiak, A. (2021). Structure of papain\u2010like protease from SARS\u2010CoV\u20102 and its complexes with non\u2010covalent inhibitors. Nature Communications, 12(1), 743.", "ArticleIdList": ["PMC7854729", "33531496"]}, {"Citation": "Pandeya, K. B. , Ganeshpurkar, A. , & Mishra, M. K. (2020). Natural RNA dependent RNA polymerase inhibitors: Molecular docking studies of some biologically active alkaloids of Argemone mexicana . Medical Hypotheses, 144, 109905.", "ArticleIdList": ["PMC7262531", "32535456"]}, {"Citation": "P\u00e1ramo, J. A. (2020). Respuesta inflamatoria en relaci\u00f3n con COVID\u201019 y otros fenotipos protomb\u00f3ticos. Reumatolog\u00eda Cl\u00ednica, 1(1), 1\u20134."}, {"Citation": "Persoons, L. , Vanderlinden, E. , Vangeel, L. , Wang, X. , Dan, N. , Do, T. , \u2026 Jonghe, S. D. (2020). Broad spectrum anti\u2010coronavirus activity of a series of anti\u2010malaria quinoline analogues. Antiviral Research, 193, 1\u20136.", "ArticleIdList": ["PMC8247284", "34217752"]}, {"Citation": "Pizzorno, A. , Padey, B. , Dubois, J. , Julien, T. , Traversier, A. , Duli\u00e8re, V. , \u2026 Terrier, O. (2020). In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS\u2010CoV\u20102. Antiviral Research, 181. 10.1016/j.antiviral.2020.104878", "ArticleIdList": ["10.1016/j.antiviral.2020.104878", "PMC7361110", "32679055"]}, {"Citation": "Pooja, M. , Reddy, G. J. , Hema, K. , Dodoala, S. , & Koganti, B. (2021). Unravelling high\u2010affinity binding compounds towards transmembrane protease serine 2 enzyme in treating SARS\u2010CoV\u20102 infection using molecular modelling and docking studies. European Journal of Pharmacology, 890, 1\u201312.", "ArticleIdList": ["PMC7598566", "33130280"]}, {"Citation": "Qiao, Z. , Zhang, H. , Ji, H. F. , & Chen, Q. (2020). Computational view toward the inhibition of SARS\u2010CoV\u20102 spike glycoprotein and the 3CL protease. Computation, 8(2), 1\u20139.", "ArticleIdList": ["PMC7357730", "32661494"]}, {"Citation": "Quimque, M. T. J. , Notarte, K. I. R. , Fernandez, R. A. T. , Mendoza, M. A. O. , Liman, R. A. D. , Lim, J. A. K. , \u2026 Macabeo, A. P. G. (2020). Virtual screening\u2010driven drug discovery of SARS\u2010CoV2 enzyme inhibitors targeting viral attachment, replication, post\u2010translational modification and host immunity evasion infection mechanisms. Journal of Biomolecular Structure and Dynamics. 10.1080/07391102.2020.1776639", "ArticleIdList": ["10.1080/07391102.2020.1776639", "PMC7309309", "32476574"]}, {"Citation": "Rahman, N. , Basharat, Z. , Yousuf, M. , Castaldo, G. , Rastrelli, L. , & Khan, H. (2020). Virtual screening of natural products against type II transmembrane serine protease (TMPRSS2), the priming agent of coronavirus 2 (SARS\u2010CoV\u20102). Molecules (Basel, Switzerland), 25(10). 10.3390/molecules25102271", "ArticleIdList": ["10.3390/molecules25102271", "PMC7287752", "32408547"]}, {"Citation": "Ren, P. X. , Shang, W. J. , Yin, W. C. , Ge, H. , Wang, L. , Zhang, X. L. , \u2026 Bai, F. (2021). A multi\u2010targeting drug design strategy for identifying potent anti\u2010SARS\u2010CoV\u20102 inhibitors. Acta Pharmacologica Sinica, 1\u201311. 10.1038/s41401-021-00668-7", "ArticleIdList": ["10.1038/s41401-021-00668-7", "PMC8076879", "33907306"]}, {"Citation": "Ribeiro, S. A. , Lopes, C. , Amaral, R. , & Amaral, A. (2020). The therapeutic potential of colchicine in the complications of COVID\u201019. Could the immunometabolic properties of an old and cheap drug help? Metabolism Open, 7, 100045.", "ArticleIdList": ["PMC7373059", "32808940"]}, {"Citation": "Romero\u2010Mart\u00ednez, B. S. , Monta\u00f1o, L. M. , Sol\u00eds\u2010Chagoy\u00e1n, H. , Sommer, B. , Ram\u00edrez\u2010Salinas, G. L. , P\u00e9rez\u2010Figueroa, G. E. , & Flores\u2010Soto, E. (2021). Possible beneficial actions of caffeine in sars\u2010cov\u20102. International Journal of Molecular Sciences, 22(11), 1\u201312.", "ArticleIdList": ["PMC8196824", "34067243"]}, {"Citation": "Rosa, R. B. , Dantas, W. M. , do Nascimento, J. C. F. , da Silva, M. V. , de Oliveira, R. N. , & Pena, L. J. (2021). In vitro and in vivo models for studying SARS\u2010CoV\u20102, the etiological agent responsible for COVID\u201019 pandemic. Viruses, 13(3). 10.3390/v13030379", "ArticleIdList": ["10.3390/v13030379", "PMC7997194", "33673614"]}, {"Citation": "Sandhu, T. , Tieng, A. , Chilimuri, S. , & Franchin, G. (2020). A case control study to evaluate the impact of colchicine on patients admitted to the hospital with moderate to severe COVID\u201019 infection. Canadian Journal of Infectious Diseases and Medical Microbiology, 2020, 1\u20139.", "ArticleIdList": ["PMC7588830", "33133323"]}, {"Citation": "Scarsi, M. , Piantoni, S. , Colombo, E. , Air\u00f3, P. , Richini, D. , Miclini, M. , \u2026 Andreoli, L. (2020). Association between treatment with colchicine and improved survival in a single\u2010Centre cohort of adult hospitalised patients with COVID\u201019 pneumonia and acute respiratory distress syndrome. Annals of the Rheumatic Diseases, 79(10), 1286\u20131289.", "ArticleIdList": ["PMC7509521", "32732245"]}, {"Citation": "Shang, X. F. , Yang, C. J. , Morris\u2010Natschke, S. L. , Li, J. C. , Yin, X. D. , Liu, Y. Q. , \u2026 Lee, K. H. (2020). Biologically active isoquinoline alkaloids covering 2014\u20132018. Medicinal Research Reviews, 40(6), 2212\u20132289.", "ArticleIdList": ["PMC7554109", "32729169"]}, {"Citation": "Sharma, K. , Morla, S. , Goyal, A. , & Kumar, S. (2020). Computational guided drug repurposing for targeting 2\u2032\u2010O\u2010ribose methyltransferase of SARS\u2010CoV\u20102. Life Sciences. 10.1016/j.lfs.2020.118169", "ArticleIdList": ["10.1016/j.lfs.2020.118169", "PMC7387922", "32738360"]}, {"Citation": "Shen, L. , Niu, J. , Wang, C. , Huang, B. , Wang, W. , Zhu, N. , \u2026 Tan, W. (2019). High\u2010throughput screening and identification of potent broad\u2010spectrum inhibitors of coronaviruses. Journal of Virology, 93(12), 1\u201315.", "ArticleIdList": ["PMC6613765", "30918074"]}, {"Citation": "Sim\u00f5es, C. M. O. , Schenkel, E. P. , de Mello, J. C. P. , Mentz, L. A. , & Petrovick, P. R. (2017). Farmacognosia: do produto natural ao medicamento. Porto Alegre, Brazil: Artmed."}, {"Citation": "Sisakht, M. , Mahmoodzadeh, A. , & Darabian, M. (2021). Plant\u2010derived chemicals as potential inhibitors of SARS\u2010CoV\u20102 main protease (6LU7), a virtual screening study. Phytotherapy Research, 35(6), 3262\u20133274.", "ArticleIdList": ["PMC8251402", "33759279"]}, {"Citation": "Skariyachan, S. , Gopal, D. , Muddebihalkar, A. G. , & Uttarkar, A. (2021). Structural insights on the interaction potential of natural leads against major protein targets of SARS\u2010CoV\u20102: Molecular modelling, docking and dynamic simulation studies. Computers in Biology and Medicine, 132, 1\u201324.", "ArticleIdList": ["PMC7954774", "33751995"]}, {"Citation": "Sohrabi, C. , Alsafi, Z. , O'Neill, N. , Khan, M. , Kerwan, A. , Al\u2010Jabir, A. , \u2026 Agha, R. (2020). World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID\u201019). International Journal of Surgery. 10.1016/j.ijsu.2020.02.034", "ArticleIdList": ["10.1016/j.ijsu.2020.02.034", "PMC7105032", "32112977"]}, {"Citation": "Stringer, D. , Braude, P. , Myint, P. K. , Evans, L. , Collins, J. T. , Verduri, A. , \u2026 Carter, B. (2021). The role of C\u2010reactive protein as a prognostic marker in COVID\u201019. International Journal of Epidemiology, 50(2), 420\u2013429.", "ArticleIdList": ["PMC7989395", "33683344"]}, {"Citation": "Sultana, J. , Crisafulli, S. , Gabbay, F. , Lynn, E. , Shakir, S. , & Trifir\u00f2, G. (2020). Challenges for drug repurposing in the COVID\u201019 pandemic era. Frontiers in Pharmacology, 11, 1\u201313.", "ArticleIdList": ["PMC7677570", "33240091"]}, {"Citation": "Sumitha, A. , Devi, P. B. , Hari, S. , & Dhanasekaran, R. (2020). COVID\u201019\u2014In silico structure prediction and molecular docking studies with doxycycline and quinine. Biomedical and Pharmacology Journal, 13(3), 1185\u20131193."}, {"Citation": "Tao, K. , Tzou, P. L. , Nouhin, J. , Gupta, R. K. , de Oliveira, T. , Kosakovsky Pond, S. L. , \u2026 Shafer, R. W. (2021). The biological and clinical significance of emerging SARS\u2010CoV\u20102 variants. Nature Reviews Genetics, 22(12), 757\u2013773.", "ArticleIdList": ["PMC8447121", "34535792"]}, {"Citation": "Tardif, J. C. , Bouabdallaoui, N. , L'Allier, P. L. , Gaudet, D. , Shah, B. , Pillinger, M. H. , \u2026 Boivin, G. (2021). Colchicine for community\u2010treated patients with COVID\u201019 (COLCORONA): A phase 3, randomised, double\u2010blinded, adaptive, placebo\u2010controlled, multicentre trial. The Lancet Respiratory Medicine, 9(8), 924\u2013932.", "ArticleIdList": ["PMC8159193", "34051877"]}, {"Citation": "Tricco, A. C. , Lillie, E. , Zarin, W. , O'Brien, K. K. , Colquhoun, H. , Levac, D. , \u2026 Hempel, S. (2018). PRISMA extension for scoping reviews (PRISMA\u2010ScR): Checklist and explanation. Annals of Internal Medicine, 169(7), 467\u2013473.", "ArticleIdList": ["30178033"]}, {"Citation": "V'Kovski, P. , Kratzel, A. , Steiner, S. , Stalder, H. , & Thiel, V. (2021). Coronavirus biology and replication: Implications for SARS\u2010CoV\u20102. Nature Reviews Microbiology, 19(3), 155\u2013170.", "ArticleIdList": ["PMC7592455", "33116300"]}, {"Citation": "Varghese, F. S. , van Woudenbergh, E. , Overheul, G. J. , Eleveld, M. J. , Kurver, L. , van Heerbeek, N. , \u2026 van Rij, R. P. (2021). Berberine and obatoclax inhibit SARS\u2010CoV\u20102 replication in primary human nasal epithelial cells in vitro . Viruses, 12(282), 1\u201317.", "ArticleIdList": ["PMC7918080", "33670363"]}, {"Citation": "Venkatesan, P. (2021). Repurposing drugs for treatment of COVID\u201019. The Lancet. Respiratory Medicine. 10.1016/s2213-2600(21)00270-8", "ArticleIdList": ["10.1016/s2213-2600(21)00270-8", "PMC8175045", "34090608"]}, {"Citation": "Verma, S. , Twilley, D. , Esmear, T. , Oosthuizen, C. B. , Reid, A. M. , Nel, M. , & Lall, N. (2020). Anti\u2010SARS\u2010CoV natural products with the potential to inhibit SARS\u2010CoV\u20102 (COVID\u201019). Frontiers in Pharmacology, 11. 10.3389/fphar.2020.561334", "ArticleIdList": ["10.3389/fphar.2020.561334", "PMC7546787", "33101023"]}, {"Citation": "Wu, C. , Chen, X. , Cai, Y. , Xia, J. , Zhou, X. , Xu, S. , \u2026 Song, Y. (2020). Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Internal Medicine, 180(7), 934\u2013943.", "ArticleIdList": ["PMC7070509", "32167524"]}, {"Citation": "Yang, J. , Petitjean, S. J. L. , Koehler, M. , Zhang, Q. , Dumitru, A. C. , Chen, W. , \u2026 Alsteens, D. (2020). Molecular interaction and inhibition of SARS\u2010CoV\u20102 binding to the ACE2 receptor. Nature Communications, 11(1), 4541.", "ArticleIdList": ["PMC7486399", "32917884"]}, {"Citation": "Yang, S. , Xu, M. , Lee, E. M. , Gorshkov, K. , Shiryaev, S. A. , He, S. , \u2026 Zheng, W. (2018). Emetine inhibits Zika and Ebola virus infections through two molecular mechanisms: Inhibiting viral replication and decreasing viral entry. Cell Discovery, 4(1), 1\u201314.", "ArticleIdList": ["PMC5986771", "29872540"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "2", "Day": "22"}, {"Year": "2021", "Month": "10", "Day": "30"}, {"Year": "2022", "Month": "3", "Day": "4"}, {"Year": "2022", "Month": "4", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "7", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "3", "Day": "31", "Hour": "5", "Minute": "15"}, {"Year": "2022", "Month": "3", "Day": "30"}], "PublicationStatus": "ppublish", "ArticleIdList": ["35355337", "PMC9111026", "10.1002/ptr.7442"]}}], "PubmedBookArticle": []}